Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2022-04-11 Major Shareholding Noti…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is very short (287 characters) and contains a tabular disclosure under Regulation 31(4), which relates to shareholding or promoter disclosures. It lists a promoter's name and financial year end but does not contain financial statements or detailed report content. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document is not an announcement of a report nor a full report itself, and it is not a certification or other regulatory filing. Therefore, the best classification is MRQ with high confidence.
2022-04-11 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is very short (293 characters) and contains a tabular disclosure under Regulation 31(4) related to shareholding or promoter information for a financial year end date. This matches the description of a Major Shareholding Notification, which reports changes or holdings of significant shareholders or promoters. There is no indication of financial statements, management discussion, or other report types. Therefore, the document is best classified as a Major Shareholding Notification (MRQ).
2022-04-11 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is very short (286 characters) and contains a tabular disclosure under Regulation 31(4), which relates to shareholding or promoter disclosures. It lists a promoter's name and financial year end but does not contain financial statements or detailed report content. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document is not an announcement of a report nor a full report itself, and it is not a certification or other regulatory filing. Therefore, the best classification is MRQ with high confidence.
2022-04-11 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is very short (287 characters) and contains a tabular disclosure under Regulation 31(4) related to shareholding or promoter information for a financial year ending 31-Mar-2022. This matches the description of a Major Shareholding Notification, which involves reporting changes or holdings of significant shareholders or promoters. There is no indication of a full report, financial statements, or other detailed filings. Therefore, the document fits best under Major Shareholding Notification (MRQ).
2022-04-11 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma & PACs
Regulatory Filings
2022-04-04 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Vishal Rao & PACs
Regulatory Filings
2022-04-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.